Unknown

Dataset Information

Efficacy and safety of warfarin in patients with non-valvular atrial fibrillation and CKD G3-G5D.


ABSTRACT:

Background

Observational data comparing warfarin with no treatment for patients with non-valvular atrial fibrillation (NVAF) and severely reduced glomerular filtration rate (GFR) are conflicting and randomized controlled trials (RCTs) are lacking. Most studies do not provide information on warfarin treatment quality, making them difficult to compare.

Methods

This national cohort study investigates the risk of ischaemic stroke and major bleeding during warfarin treatment compared with no oral anticoagulants in patients with NVAF, GFR category 3-5 (G3-G5) or on dialysis (G5D), with kidney transplant recipients excluded, between 2009 and 2018. Data extracted from high-quality Swedish national healthcare registries, including the Swedish Renal Registry, AuriculA-the Swedish nati

SUBMITTER: Welander F 

PROVIDER: S-EPMC9155221 | biostudies-literature | 2022 Jun

REPOSITORIES: biostudies-literature